Literature DB >> 12456323

Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell.

Erwin Gäbele1, David A Brenner, Richard A Rippe.   

Abstract

Liver fibrosis represents a major medical problem with significant morbidity and mortality. Worldwide hepatitis viral infections represent the major cause liver fibrosis; however, within the United States chronic ethanol consumption is the leading cause of hepatic fibrosis. Other known stimuli for liver fibrosis include helminthic infection, iron or copper overload and biliary obstruction. Fibrosis can be classified as a wound healing response to a variety of chronic stimuli that is characterized by an excessive deposition of extracellular matrix proteins of which type I collagen predominates. This excess deposition of extracellular matrix proteins disrupts the normal architecture of the liver resulting in pathophysiological damage to the organ. If left untreated fibrosis can progress to liver cirrhosis ultimately leading to organ failure and death if left untreated. This review will discuss the molecular events leading to liver fibrosis. The discussion will include collagen gene regulation and proliferative signals that contribute to the amplification of the hepatic stellate cell, the primary fibrogenic cell type that resides in the liver.

Entities:  

Mesh:

Year:  2003        PMID: 12456323     DOI: 10.2741/887

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  62 in total

1.  Extracellular matrix bioengineering and systems biology approaches in liver disease.

Authors:  Natalia Nieto; Matthias P Lutolf
Journal:  Syst Synth Biol       Date:  2011-06-17

2.  Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling.

Authors:  Raquel Urtasun; Aritz Lopategi; Joseph George; Tung-Ming Leung; Yongke Lu; Xiaodong Wang; Xiaodong Ge; Maria Isabel Fiel; Natalia Nieto
Journal:  Hepatology       Date:  2012-02       Impact factor: 17.425

Review 3.  Treatment of fibrosis in nonalcoholic fatty liver disease.

Authors:  Maarouf A Hoteit; Frank A Anania
Journal:  Curr Gastroenterol Rep       Date:  2007-03

4.  Fibrosis and subsequent cytopenias are associated with basic fibroblast growth factor-deficient pluripotent mesenchymal stromal cells in large granular lymphocyte leukemia.

Authors:  Adam W Mailloux; Ling Zhang; Lynn Moscinski; John M Bennett; Lili Yang; Sean J Yoder; Gregory Bloom; Cody Wei; Sheng Wei; Lubomir Sokol; Thomas P Loughran; Pearlie K Epling-Burnette
Journal:  J Immunol       Date:  2013-09-06       Impact factor: 5.422

5.  Loss of discoidin domain receptor 2 promotes hepatic fibrosis after chronic carbon tetrachloride through altered paracrine interactions between hepatic stellate cells and liver-associated macrophages.

Authors:  Elvira Olaso; Beatriz Arteta; Aitor Benedicto; Olatz Crende; Scott L Friedman
Journal:  Am J Pathol       Date:  2011-10-19       Impact factor: 4.307

6.  Inhibitory effect of nuclear factor-κB decoy oligodeoxynucleotide on liver fibrosis through regulation of the epithelial-mesenchymal transition.

Authors:  Kyung-Hyun Kim; Woo-Ram Lee; Yu-Na Kang; Young-Chae Chang; Kwan-Kyu Park
Journal:  Hum Gene Ther       Date:  2014-08       Impact factor: 5.695

7.  Alcoholic liver disease: a synopsis of the Charles Lieber's Memorial Symposia 2009-2012.

Authors:  Manuela G Neuman; Lawrence Cohen; Samir Zakhari; Radu M Nanau; Sebastian Mueller; Michelle Schneider; Charles Parry; Romina Isip; Helmut K Seitz
Journal:  Alcohol Alcohol       Date:  2014-05-09       Impact factor: 2.826

8.  Inhibition of connective tissue growth factor suppresses hepatic stellate cell activation in vitro and prevents liver fibrosis in vivo.

Authors:  Chunqiu Hao; Yumei Xie; Meijuan Peng; Li Ma; Yun Zhou; Yan Zhang; Wenzhen Kang; Jiuping Wang; Xuefan Bai; Pingzhong Wang; Zhansheng Jia
Journal:  Clin Exp Med       Date:  2013-03-02       Impact factor: 3.984

9.  Changes in E-NTPDase 3 expression and extracellular nucleotide hydrolysis during the myofibroblast/lipocyte differentiation.

Authors:  Cláudia M B Andrade; Márcia R Wink; Rogério Margis; Radovan Borojevic; Ana Maria O Battastini; Fátima C R Guma
Journal:  Mol Cell Biochem       Date:  2010-01-08       Impact factor: 3.396

10.  New role and molecular mechanism of Gadd45a in hepatic fibrosis.

Authors:  Liang Hong; Qing-Feng Sun; Ting-Yan Xu; Yang-He Wu; Hui Zhang; Rong-Quan Fu; Fu-Jing Cai; Qing-Qing Zhou; Ke Zhou; Qing-Wei Du; Dong Zhang; Shuang Xu; Ji-Guang Ding
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.